Code is for vertebral compression fracture detection with CT scans.
Zebra Medical Vision announced July 7 it has received approval of its CPT application for using artificial intelligence (AI) with CT scans to detect vertebral compression fractures (VCF) from the American Medical Association (AMA).
This is the first AI CPT code specific to radiology.
“The latest development regarding the CPT code approval by the AMA is an industry milestone in the effort to boost the adoption of AI in imaging for VCFs and other under-diagnosed chronic conditions for which can help reveal and drive care,” said Zohar Elhanani, Zebra Medical Vision chief executive officer. “Radiologists will now be able to identify more patients with undiagnosed fractures and provide better care for patients who may be vulnerable.”
Osteoporotic fractures affect nearly 50 percent of men and 25 percent of women during their lifetimes, resulting in 2 million broken bones annually and an estimated $52 billion cost to the U.S. healthcare system. Still, Zebra Medical officials said, 75 percent of these fractures go undetected.
According to existing data, Zebra Medical’s VCF solution can increase detection rates, bringing needed treatment to more patients without addition imaging or radiation. With this CPT code in place, providers using the tool will be able to submit for reimbursement, potentially increasing its use.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.